BGM
BGM Group Ltd.NASDAQHealthcare$0.34-1.13%ClosedMarket Cap: $67.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.06
P/S
2.66
EV/EBITDA
64.82
DCF Value
$1.68
FCF Yield
-5.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
16.4%
Operating Margin
-2.2%
Net Margin
-5.7%
ROE
-3.4%
ROA
-2.7%
ROIC
-0.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $14.3M | 14.5% | $-2.2M | $-861.2K | $-0.03 | — |
| FY 2024 | $25.1M | 16.4% | $-563.8K | $-1.4M | $-0.20 | — |
| Q2 2024 | $12.6M | 11.3% | $-679.1K | $328.8K | $0.05 | — |
| FY 2023 | $46.5M | 3.8% | $-2.6M | $-7.8M | $-1.08 | $0.05 |
| FY 2022 | $64.9M | 9.6% | $2.1M | $1.1M | $0.15 | — |
| FY 2021 | $57.1M | 9.9% | $2.4M | $3.2M | $0.45 | — |
| FY 2020 | $50.0M | 15.1% | $4.8M | $5.1M | $0.72 | — |
| FY 2019 | $46.1M | 21.0% | $6.2M | $5.3M | $0.76 | — |
| FY 2018 | $50.4M | 16.1% | $6.0M | $5.2M | $0.74 | — |
| FY 2017 | $22.5M | 15.0% | $1.1M | $1.4M | $0.20 | — |